The Q3 2025 Newsletter

The Q3 2025 HORUS newsletter highlights progress in the collaborative European project tackling cytomegalovirus (CMV) infection in solid organ transplant patients. With 24 partners across heart, liver, kidney, and lung transplants, the team is advancing research to identify signatures linked to CMV control and severity. Key updates include completed sample work for data analysis, recent presentations at major conferences, and interviews with team members.

Next
Next

Interview with Anaïs Schneller: Her Role in Shaping Personalised Transplant Medicine